Across TCGA pan-cancer cohorts, LILRB1-AS1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LILRB1-AS1 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher LILRB1-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LILRB1-AS1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and HNSC show a favorable association.

LUSC, SKCM, and KICH are the cancer types where LILRB1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.299	0.428	.004	72	view →
SKCM	OS	Tertile	II,III,IV	0.573	0.328	.002	66	view →
KICH	DFS	Tertile	All	0.521	0.971	<.001	45	view →
HNSC	OS	Tertile	All	0.892	0.736	.006	39	view →
LGG	OS	Tertile	All	0.706	0.835	<.001	30	view →
ESCA	OS	Tertile	II,III,IV	0.382	0.701	.005	18	view →
MESO	DFS	Tertile	All	0.138	0.481	.031	18	view →
TGCT	DFS	Tertile	II,III,IV	0.526	0.951	.011	18	view →
CHOL	DFS	Quartile	II,III,IV	0.792	0.133	.024	9	view →
LUAD	DFS	Tertile	III,IV	0.402	0.705	.026	9	view →
COAD	DFS	Tertile	IV	0.035	0.501	<.001	9	view →
UCEC	DFS	Tertile	All	0.819	0.900	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

Exploration

Same gene, other analysis: LILRB1-AS1 tumor-vs-normal RNA expression · all LILRB1-AS1 data types